
Annual healthcare costs jump by almost $25,000 with targeted therapy for atopic dermatitis that avoided costs from reduced hospitalizations and ER visits only partly offset, according to recently reported research findings.
New Indication: Injectable PPI cleared for hypersecretion due to Zollinger-Ellison syndrome






